Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis

Bo Lu, Ryan Morrison, Stephen M. Schleicher, Yunguang Sun, Kenneth J. Niermann, Sungjune Kim, Daniel E. Spratt, Christine H. Chung

Research output: Contribution to journalArticlepeer-review

Abstract

Despite advances in treatment, cancer remains the 2nd most common cause of death in the United States. Poor cure rates may result from the ability of cancer to recur and spread after initial therapies have seemingly eliminated detectable signs of disease. A growing body of evidence supports a role for cancer stem cells (CSCs) in tumor regrowth and spread after initial treatment. Thus, targeting CSCs in combination with traditional induction therapies may improve treatment outcomes and survival rates. Unfortunately, CSCs tend to be resistant to chemo- and radiation therapy, and a better understanding of the mechanisms underlying CSC resistance to treatment is necessary. This paper provides an update on evidence that supports a fundamental role for CSCs in cancer progression, summarizes potential mechanisms of CSC resistance to treatment, and discusses classes of drugs currently in preclinical or clinical testing that show promise at targeting CSCs.

Original languageEnglish (US)
Article number941876
JournalJournal of Oncology
DOIs
StatePublished - 2011
Externally publishedYes

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis'. Together they form a unique fingerprint.

Cite this